J. Goldman & Co’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-493,462
Closed -$11.2M – 445
2025
Q2
$11.2M Sell
493,462
-415,997
-46% -$9.86M 0.27% 122
2025
Q1
$27.6M Buy
909,459
+277,508
+44% +$10.6M 0.68% 29
2024
Q4
$25.1M Buy
+631,951
New +$28.5M 0.65% 36
2016
Q4
– Sell
-17,000
Closed -$842K – 290
2016
Q3
$842K Buy
+17,000
New +$885K 0.05% 249

Other funds holding ACHC

J. Goldman & Co's ACHC Position: Q3 2025 in Review

J. Goldman & Co sold out of Acadia Healthcare (ACHC) in Q3 2025, closing a stake of 493,462 shares — an estimated $11.2M sold.

J. Goldman & Co first reported a position in ACHC in Q3 2016 and held it in 4 quarters. The position peaked at $27.6M in Q1 2025. 270 funds tracked by Wall St. Rank hold ACHC as of Q3 2025.

  • J. Goldman & Co reported no remaining Acadia Healthcare position as of Q3 2025 after selling out during the quarter.
  • J. Goldman & Co sold 493,462 Acadia Healthcare shares in Q3 2025, an estimated $11.2M.
  • J. Goldman & Co first reported a position in Acadia Healthcare in Q3 2016 and held it in 4 quarters.
  • J. Goldman & Co's Acadia Healthcare position peaked at $27.6M in Q1 2025.
  • 270 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2025.

Based on J. Goldman & Co's 13F filing for Q3 2025, filed 14 Nov 2025.